Osteoarthritis (OA) is a painful, degenerative and inflammatory disease that affects the entire synovial joints. Nowadays, no cure exists, and the pharmacological treatments are limited to symptoms alleviation. There is a need for a new efficient and safe treatment. Viscosupplementation is a process that aims to restore the normal rheological properties of synovial fluid. For the past years, hyaluronic acid was usually used but this molecule has some limitations including the short residency time in joint cavity. Recently, in vitro studies have suggested that chitosan could promote the expression of cartilage matrix components and reduce inflammatory and catabolic mediator’s production by chondrocytes. In vivo, chitosan prevented cartilage degradation and synovial membrane inflammation in OA induced rabbit model. Several studies have also shown that chitosan could induce chondrogenic differentiation of mesenchymal stem cells. Therefore, chitosan is an interesting polymer to design scaffold and hydrogel for cartilage lesion repair, cells transplantation, sustained drug release and viscosupplementation.
KeeneyM.LaiJ.H. and YangF., Recent progress in cartilage tissue engineering, Curr. Opin. Biotechnol.22 (2011), 734–740. doi:10.1016/j.copbio.2011.04.003.
2.
HunzikerE.B., Articular cartilage repair: Basic science and clinical progress. A review of the current status and prospects, Osteoarthritis Cartilage10 (2002), 432–463. doi:10.1053/joca.2002.0801.
3.
SongK.LiL.YanX.ZhangY.LiR.WangY.WangL.WangH. and LiuT., Fabrication and development of artificial osteochondral constructs based on cancellous bone/hydrogel hybrid scaffold, J. Mater. Sci. Mater. Med.27 (2016), 114. doi:10.1007/s10856-016-5722-5.
4.
KarsdalM.A.MichaelisM.LadelC.SiebuhrA.S.BihletA.R.AndersenJ.R.GuehringH.ChristiansenC.Bay-JensenA.C. and KrausV.B., Disease-modifying treatments for osteoarthritis (DMOADs) of the knee and hip: Lessons learned from failures and opportunities for the future, Osteoarthritis Cartilage24 (2016), 2013–2021. doi:10.1016/j.joca.2016.07.017.
5.
Le ClancheS.Bonnefont-RousselotD.Sari-AliE.RannouF. and BorderieD., Inter-relations between osteoarthritis and metabolic syndrome: A common link?, Biochimie121 (2016), 238–252. doi:10.1016/j.biochi.2015.12.008.
6.
NelsonA.E.AllenK.D.GolightlyY.M.GoodeA.P. and JordanJ.M., A systematic review of recommendations and guidelines for the management of osteoarthritis: The Chronic Osteoarthritis Management Initiative of the U.S. Bone and Joint Initiative, Semin. Arthritis Rheum.43 (2014), 701–712. doi:10.1016/j.semarthrit.2013.11.012.
7.
HochbergM.C., Osteoarthritis year 2012 in review: Clinical, Osteoarthritis Cartilage20 (2012), 1465–1469. doi:10.1016/j.joca.2012.07.022.
8.
McAlindonT.E.BannuruR.R.SullivanM.C.ArdenN.K.BerenbaumF.Bierma-ZeinstraS.M.HawkerG.A.HenrotinY.HunterD.J.KawaguchiH.KwohK.LohmanderS.RannouF.RoosE.M. and UnderwoodM., OARSI guidelines for the non-surgical management of knee osteoarthritis, Osteoarthritis Cartilage22 (2014), 363–388. doi:10.1016/j.joca.2014.01.003.
9.
CarterG.T.DuongV.HoS.NgoK.C.GreerC.L. and WeeksD.L., Side effects of commonly prescribed analgesic medications, Phys. Med. Rehabil. Clin. N. Am.25 (2014), 457–470. doi:10.1016/j.pmr.2014.01.007.
10.
OprenyeszkF.SanchezC.DubucJ.E.MaquetV.HenristC.CompereP. and HenrotinY., Chitosan enriched three-dimensional matrix reduces inflammatory and catabolic mediators production by human chondrocytes, PLoS One10 (2015), e0128362. doi:10.1371/journal.pone.0128362.
11.
LogithKumarR.KeshavNarayanA.DhivyaS.ChawlaA.SaravananS. and SelvamuruganN., A review of chitosan and its derivatives in bone tissue engineering, Carbohydr. Polym.151 (2016), 172–188. doi:10.1016/j.carbpol.2016.05.049.
12.
MuzzarelliR.A.El MehtediM.BottegoniC. and GiganteA., Physical properties imparted by genipin to chitosan for tissue regeneration with human stem cells: A review, Int. J. Biol. Macromol.93 (2016), 1366–1381. doi:10.1016/j.ijbiomac.2016.03.075.
13.
LuJ.X.PrudhommeauxF.MeunierA.SedelL. and GuilleminG., Effects of chitosan on rat knee cartilages, Biomaterials20 (1999), 1937–1944. doi:10.1016/S0142-9612(99)00097-6.
14.
LahijiA.SohrabiA.HungerfordD.S. and FrondozaC.G., Chitosan supports the expression of extracellular matrix proteins in human osteoblasts and chondrocytes, J. Biomed. Mater. Res.51 (2000), 586–595. doi:10.1002/1097-4636(20000915)51:4<586::AID-JBM6>3.0.CO;2-S.
15.
JordanK.M.ArdenN.K.DohertyM.BannwarthB.BijlsmaJ.W.DieppeP.GuntherK.HauselmannH.Herrero-BeaumontG.KaklamanisP.LohmanderS.LeebB.LequesneM.MazieresB.Martin-MolaE.PavelkaK.PendletonA.PunziL.SerniU.SwobodaB.VerbruggenG.Zimmerman-GorskaI.DougadosM. and Standing Committee for International Clinical Studies Including Therapeutic Trials ESCISIT, EULAR recommendations 2003: An evidence based approach to the management of knee osteoarthritis: Report of a task force of the Standing Committee for International Clinical Studies Including Therapeutic Trials (ESCISIT), Ann. Rheum. Dis.62 (2003), 1145–1155. doi:10.1136/ard.2003.011742.
16.
ZhangW.MoskowitzR.W.NukiG.AbramsonS.AltmanR.D.ArdenN.Bierma-ZeinstraS.BrandtK.D.CroftP.DohertyM.DougadosM.HochbergM.HunterD.J.KwohK.LohmanderL.S. and TugwellP., OARSI recommendations for the management of hip and knee osteoarthritis, part II: OARSI evidence-based, expert consensus guidelines, Osteoarthritis Cartilage16 (2008), 137–162. doi:10.1016/j.joca.2007.12.013.
17.
BrandtK.D.SmithG.N.Jr. and SimonL.S., Intraarticular injection of hyaluronan as treatment for knee osteoarthritis: What is the evidence?, Arthritis Rheum.43 (2000), 1192–1203. doi:10.1002/1529-0131(200006)43:6<1192::AID-ANR2>3.0.CO;2-L.
18.
OprenyeszkF.ChaussonM.MaquetV.DubucJ.E. and HenrotinY., Protective effect of a new biomaterial against the development of experimental osteoarthritis lesions in rabbit: A pilot study evaluating the intra-articular injection of alginate–chitosan beads dispersed in an hydrogel, Osteoarthritis Cartilage21 (2013), 1099–1107. doi:10.1016/j.joca.2013.04.017.
19.
DewanA.K.GibsonM.A.ElisseeffJ.H. and TriceM.E., Evolution of autologous chondrocyte repair and comparison to other cartilage repair techniques, Biomed. Res. Int.2014 (2014), 272481.
20.
KerkerJ.T.LeoA.J. and SgaglioneN.A., Cartilage repair: Synthetics and scaffolds: Basic science, surgical techniques, and clinical outcomes, Sports Medicine and Arthroscopy Review16 (2008), 208–216. doi:10.1097/JSA.0b013e31818cdbaa.
21.
HenrotinY. and DubucJ.E., Cartilage repair in osteoarthritic patients: Utopia or real opportunity?, F1000 Medicine Reports1 (2009), 88.
22.
GuoC.A.LiuX.G.HuoJ.Z.JiangC.WenX.J. and ChenZ.R., Novel gene-modified-tissue engineering of cartilage using stable transforming growth factor--transfected mesenchymal stem cells grown on chitosan scaffolds, J. Biosci. Bioeng.103 (2007), 547–556. doi:10.1263/jbb.103.547.
23.
StanishW.D.McCormackR.ForriolF.MohtadiN.PeletS.DesnoyersJ.RestrepoA. and ShiveM.S., Novel scaffold-based BST-CarGel treatment results in superior cartilage repair compared with microfracture in a randomized controlled trial, J. Bone Joint Surg. Am.95 (2013), 1640–1650. doi:10.2106/JBJS.L.01345.
24.
KangM.L.KimJ.E. and ImG.I., Thermoresponsive nanospheres with independent dual drug release profiles for the treatment of osteoarthritis, Acta Biomater.39 (2016), 65–78. doi:10.1016/j.actbio.2016.05.005.
25.
DaleyE.L.ColemanR.M. and StegemannJ.P., Biomimetic microbeads containing a chondroitin sulfate/chitosan polyelectrolyte complex for cell-based cartilage therapy, Journal of Materials Chemistry. B, Materials for Biology and Medicine3 (2015), 7920–7929. doi:10.1039/C5TB00934K.
26.
MellatiA.KiamahallehM.V.MadaniS.H.DaiS.BiJ.JinB. and ZhangH., Poly (N-isopropylacrylamide) hydrogel/chitosan scaffold hybrid for three-dimensional stem cell culture and cartilage tissue engineering, J. Biomed. Mater. Res. A104 (2016), 2764–2774. doi:10.1002/jbm.a.35810.
27.
VishwanathV.PramanikK. and BiswasA., Optimization and evaluation of silk fibroin–chitosan freeze-dried porous scaffolds for cartilage tissue engineering application, J. Biomater. Sci. Polym. Ed.27 (2016), 657–674. doi:10.1080/09205063.2016.1148303.
28.
ReedS.LauG.DelattreB.LopezD.D.TomsiaA.P. and WuB.M., Macro- and micro-designed chitosan–alginate scaffold architecture by three-dimensional printing and directional freezing, Biofabrication8 (2016), 015003. doi:10.1088/1758-5090/8/1/015003.
